Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis

Oncogene

Volumn 29, Issue 20, 2010, Pages 3025-3032

  El Hour, M ^a   Moncada Pazos, A ^b   Blacher, S ^a   Masset, A ^a   Cal, S ^b   Berndt, S ^a   Detilleux, J ^a   Host, L ^a   Obaya, A J ^b   Maillard, C ^a   Foidart, J M ^a   Ectors, F ^c   Noel, A ^a   Lopez Otin, C ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF OVIEDO   (Spain)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

ADAMTS 12; Angiogenesis; Tumor suppression

Indexed keywords

MATRIGEL;

ADAMTS GENE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FERTILITY; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; KERATINOCYTE; LIFESPAN; MOUSE; NONHUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TUMOR GROWTH; VASCULAR RING;

MUS;

EID: 77952674017     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.49     Document Type: Article

References (30)

1. Bai XH, Wang DW, Luan Y, Yu XP, Liu CJ. (2009). Regulation of chondrocyte differentiation by ADAMTS-12 metallo-proteinase depends on its enzymatic activity. Cell Mol Life Sci 66: 667-680.
2. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A et al. (2003). Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 35: 252-257. (Pubitemid 37363179)
3. Berndt S, Bruyere F, Jost M, Edwards DR, Noel A. (2008). In vitro and in vivo models of angiogenesis to dissect MMP functions. In Edwards DR, Hoyer-Hansen G, Blasi F, Sloane BF (eds). The Cancer Degradome: Proteases and Cancer Biology. Springer: New-York, 305-325.
4. Berndt S, Perrier DS, Blacher S, Pequeux C, Lorquet S, Munaut C et al. (2006). Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J 20: 2630-2632. (Pubitemid 44953803)
5. Blacher S, Jost M, Melen-Lamalle L, Lund LR, Romer J, Foidart JM et al. (2008). Quantification of in vivo tumor invasion and vascularization by computerized image analysis. Microvasc Res 75: 169-178. (Pubitemid 351249861)
6. Cal S, Arguelles JM, Fernandez PL, Lopez-Otin C. (2001). Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats. J Biol Chem 276: 17932-17940. (Pubitemid 37411354)
7. Cauwe B, Van den Steen PE, Opdenakker G. (2007). The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42: 113-185. (Pubitemid 46911962)
8. Dunn JR, Reed JE, du Plessis DG, Shaw EJ, Reeves P, Gee AL et al. (2006). Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer 94: 1186-1193.
9. Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174. (Pubitemid 37328786)
10. Fusenig NE, Breitkreutz D, Dzarlieva RT, Boukamp P, Bohnert A, Tilgen W. (1983). Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. J Invest Dermatol 81: 168s-175s. (Pubitemid 13030436)
11. Iruela-Arispe ML, Carpizo D, Luque A. (2003). ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci 995: 183-190. (Pubitemid 36706625)
12. Jost M, Folgueras AR, Frerart F, Pendas A, Blacher S, Houard X et al. (2006). Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19- deficient mice. Cancer Res 66: 5234-5241. (Pubitemid 43844947)
13. Jost M, Maillard C, Lecomte J, Lambert V, Tjwa M, Blaise P et al. (2007). Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. Am J Pathol 171: 1369-1380. (Pubitemid 47582909)
14. Jost M, Vosseler S, Blacher S, Fusenig NE, Mueller MM, Noel A. (2008). The surface transplantation model to study the tumor-host interface. In Edwards DR, Hoyer-Hansen G, Blasi F, Sloane BF (eds). The Cancer Degradome: Proteases and Cancer Biology. Springer: New York, pp 327-342.
15. Kurz T, Hoffjan S, Hayes MG, Schneider D, Nicolae R, Heinzmann A et al. (2006). Fine mapping and positional candidate studies on chromosome 5p13 identify multiple asthma susceptibility loci. J Allergy Clin Immunol 118: 396-402. (Pubitemid 44142715)
16. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, Itoh T et al. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 17: 2290-2292. (Pubitemid 39561469)
17. Liu YJ, Xu Y, Yu Q. (2006). Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro-and antimetastatic activity, respectively. Oncogene 25: 2452-2467.
18. Llamazares M, Obaya AJ, Moncada-Pazos A, Heljasvaara R, Espada J, Lopez-Otin C et al. (2007). The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway. J Cell Sci 120: 3544-3552. (Pubitemid 350120947)
19. Lopez-Otin C, Matrisian LM. (2007). Emerging roles of proteases in tumour suppression. Nat Rev Cancer 7: 800-808. (Pubitemid 47463671)
20. Luque A, Carpizo DR, Iruela-Arispe ML. (2003). ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem 278: 23656-23665. (Pubitemid 36830188)
21. Masson VV, Devy L, Grignet-Debrus C, Bernt S, Bajou K, Blacher S et al. (2002). Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis. Biol Proced Online 4: 24-31. (Pubitemid 35455116)
22. Moncada-Pazos A, Obaya AJ, Fraga MF, Viloria CG, Capella G, Gausachs M et al. (2009). The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci 122: 2906-2913.
23. Mueller MM, Fusenig NE. (2004). Friends or foes\bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849.
24. Noel A, Jost M, Maquoi E. (2008). Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 19: 52-60. (Pubitemid 350235981)
25. Nyberg P, Salo T, Kalluri R. (2008). Tumor microenvironment and angiogenesis. Front Biosci 13: 6537-6553.
26. Overall CM, Blobel CP. (2007). In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 8: 245-257. (Pubitemid 46316033)
27. Porter S, Clark IM, Kevorkian L, Edwards DR. (2005). The ADAMTS metalloproteinases. Biochem J 386: 15-27.
28. Porter S, Scott SD, Sassoon EM, Williams MR, Jones JL, Girling AC et al. (2004). Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res 10: 2429-2440. (Pubitemid 38445703)
29. Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M et al. (2008). Emerging roles of ADAM and ADAMTS metallo-proteinases in cancer. Biochimie 90: 369-379. (Pubitemid 351172571)
30. Vazquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M et al. (1999). METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 274: 23349-23357. (Pubitemid 129529172)